Amylx Pharmaceuticals Inc vs Duolingo Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Duolingo Inc trades at $133.56 (market cap $6.34B). The key difference: Duolingo Inc is far larger — about 2.4× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Duolingo Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | DUOL | |
|---|---|---|
Market Cap | $2.64B | $6.34B |
Sector | Health | Technology |
52-Week High | $24.19 | $369.19 |
52-Week Low | $7.82 | $90.03 |
Enterprise Value | $2.39B | $5.11B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →